US Stock MarketDetailed Quotes

RNAZ Transcode Therapeutics

Watchlist
  • 0.515
  • +0.035+7.29%
Close Nov 4 16:00 ET
  • 0.500
  • -0.015-2.91%
Post 17:08 ET
8.89MMarket Cap-209P/E (TTM)

Transcode Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
17.99%5.11M
-32.16%3.26M
5.37%18.5M
-21.13%4.03M
23.30%5.3M
-7.24%4.33M
38.55%4.81M
198.89%17.55M
82.78%5.11M
84.63%4.3M
Selling and administrative expenses
-5.78%2.03M
-33.37%1.53M
-14.84%7.15M
-75.24%695.41K
3.95%1.98M
3.34%2.16M
43.89%2.3M
147.31%8.4M
65.15%2.81M
39.69%1.91M
-General and administrative expense
-5.78%2.03M
-33.37%1.53M
-14.84%7.15M
-75.24%695.41K
3.95%1.98M
3.34%2.16M
43.89%2.3M
147.31%8.4M
65.15%2.81M
39.69%1.91M
Research and development costs
3.90%3.08M
-32.12%1.76M
19.85%12.26M
25.19%3.36M
9.81%3.34M
13.20%2.97M
37.72%2.59M
271.55%10.23M
109.00%2.69M
206.56%3.04M
Other operating expenses
----
65.93%-27.06K
14.57%-923.04K
92.90%-27.25K
95.81%-27.44K
-2,171.63%-788.94K
-1,036.04%-79.41K
-288.18%-1.08M
-102.47%-383.77K
-1,963.81%-654.95K
Operating profit
-17.99%-5.11M
32.16%-3.26M
-5.37%-18.5M
21.13%-4.03M
-23.30%-5.3M
7.24%-4.33M
-38.55%-4.81M
-198.89%-17.55M
-82.78%-5.11M
-84.63%-4.3M
Net non-operating interest income expense
43.35%-4.3K
-10.15%-9.54K
-337.23%-50.61K
-149.49%-55.76K
-98.54%131
-670.77%-7.6K
-2,059.05%-8.66K
87.74%-11.58K
-4,482.35%-22.35K
4,788.02%9K
Non-operating interest income
-27.64%178
-96.48%168
-74.11%5.29K
-98.58%137
-98.54%131
-81.52%246
979.19%4.77K
2,973.80%20.41K
1,789.41%9.64K
6,283.69%9K
Non-operating interest expense
-42.85%4.48K
-27.72%9.71K
74.76%55.9K
----
----
--7.84K
--13.43K
-66.36%31.99K
----
----
Other net income (expense)
-72.59K
-55.35K
Gain on sale of security
---72.59K
---55.35K
----
----
----
----
----
----
----
----
Income before tax
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
-84.13%-4.29M
Income tax
Net income
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
-84.13%-4.29M
Net income continuous Operations
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
-84.13%-4.29M
Minority interest income
Net income attributable to the parent company
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
-84.13%-4.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-19.56%-5.19M
30.94%-3.33M
-5.59%-18.55M
20.38%-4.09M
-23.55%-5.3M
7.06%-4.34M
-38.81%-4.82M
-156.67%-17.56M
-83.41%-5.13M
-84.13%-4.29M
Basic earnings per share
99.48%-0.74
99.75%-0.65
90.43%-103.61
97.94%-6.5146
74.58%-67.2
50.56%-142.38
-19.94%-259.07
-67.10%-1.08K
-82.31%-316.39
-65.25%-264.4
Diluted earnings per share
99.48%-0.74
99.75%-0.65
90.43%-103.61
97.94%-6.5146
74.58%-67.2
50.56%-142.38
-19.94%-259.07
-67.10%-1.08K
-82.31%-316.39
-65.25%-264.4
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 17.99%5.11M-32.16%3.26M5.37%18.5M-21.13%4.03M23.30%5.3M-7.24%4.33M38.55%4.81M198.89%17.55M82.78%5.11M84.63%4.3M
Selling and administrative expenses -5.78%2.03M-33.37%1.53M-14.84%7.15M-75.24%695.41K3.95%1.98M3.34%2.16M43.89%2.3M147.31%8.4M65.15%2.81M39.69%1.91M
-General and administrative expense -5.78%2.03M-33.37%1.53M-14.84%7.15M-75.24%695.41K3.95%1.98M3.34%2.16M43.89%2.3M147.31%8.4M65.15%2.81M39.69%1.91M
Research and development costs 3.90%3.08M-32.12%1.76M19.85%12.26M25.19%3.36M9.81%3.34M13.20%2.97M37.72%2.59M271.55%10.23M109.00%2.69M206.56%3.04M
Other operating expenses ----65.93%-27.06K14.57%-923.04K92.90%-27.25K95.81%-27.44K-2,171.63%-788.94K-1,036.04%-79.41K-288.18%-1.08M-102.47%-383.77K-1,963.81%-654.95K
Operating profit -17.99%-5.11M32.16%-3.26M-5.37%-18.5M21.13%-4.03M-23.30%-5.3M7.24%-4.33M-38.55%-4.81M-198.89%-17.55M-82.78%-5.11M-84.63%-4.3M
Net non-operating interest income expense 43.35%-4.3K-10.15%-9.54K-337.23%-50.61K-149.49%-55.76K-98.54%131-670.77%-7.6K-2,059.05%-8.66K87.74%-11.58K-4,482.35%-22.35K4,788.02%9K
Non-operating interest income -27.64%178-96.48%168-74.11%5.29K-98.58%137-98.54%131-81.52%246979.19%4.77K2,973.80%20.41K1,789.41%9.64K6,283.69%9K
Non-operating interest expense -42.85%4.48K-27.72%9.71K74.76%55.9K----------7.84K--13.43K-66.36%31.99K--------
Other net income (expense) -72.59K-55.35K
Gain on sale of security ---72.59K---55.35K--------------------------------
Income before tax -19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M-84.13%-4.29M
Income tax
Net income -19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M-84.13%-4.29M
Net income continuous Operations -19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M-84.13%-4.29M
Minority interest income
Net income attributable to the parent company -19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M-84.13%-4.29M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -19.56%-5.19M30.94%-3.33M-5.59%-18.55M20.38%-4.09M-23.55%-5.3M7.06%-4.34M-38.81%-4.82M-156.67%-17.56M-83.41%-5.13M-84.13%-4.29M
Basic earnings per share 99.48%-0.7499.75%-0.6590.43%-103.6197.94%-6.514674.58%-67.250.56%-142.38-19.94%-259.07-67.10%-1.08K-82.31%-316.39-65.25%-264.4
Diluted earnings per share 99.48%-0.7499.75%-0.6590.43%-103.6197.94%-6.514674.58%-67.250.56%-142.38-19.94%-259.07-67.10%-1.08K-82.31%-316.39-65.25%-264.4
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data